tirzepatide gip & glp-1 Main physiological actions of the dual and agonist Frontiers | GLP-1/GIP dual agonist

PMID: 29358417 Ready when you are BPC-157 The body protection compound for accelerated healing From $169/mo compounded by a licensed 503A pharmacy, dispensed only after provider review

Rare but serious reactions include anaphylaxis and hypokalaemia during initial treatment

The Phase 2 trial (NCT04881760) tested multiple dose escalation strategies, and the Phase 3 TRIUMPH program refined these into the most effective approach

Researchers working with peptides are often trying to influence this very axis

Kandel D, et al

The mPOA represents a particularly important target, as this region integrates hormonal, sensory, and emotional inputs to regulate sexual behavior